Literature DB >> 18075499

Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia.

W H Yiu1, C-J Pan, R A Ruef, W-T Peng, M F Starost, B C Mansfield, J Y Chou.   

Abstract

Patients with glycogen storage disease type Ia (GSD-Ia) develop renal disease of unknown etiology despite intensive dietary therapies. This renal disease shares many clinical and pathological similarities to diabetic nephropathy. We studied the expression of angiotensinogen, angiotensin type 1 receptor, transforming growth factor-beta1, and connective tissue growth factor in mice with GSD-Ia and found them to be elevated compared to controls. While increased renal expression of angiotensinogen was evident in 2-week-old mice with GSD-Ia, the renal expression of transforming growth factor-beta and connective tissue growth factor did not increase for another week; consistent with upregulation of these factors by angiotensin II. The expression of fibronectin and collagens I, III, and IV was also elevated in the kidneys of mice with GSD-Ia, compared to controls. Renal fibrosis was characterized by a marked increase in the synthesis and deposition of extracellular matrix proteins in the renal cortex and histological abnormalities including tubular basement membrane thickening, tubular atrophy, tubular dilation, and multifocal interstitial fibrosis. Our results suggest that activation of the angiotensin system has an important role in the pathophysiology of renal disease in patients with GSD-Ia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075499      PMCID: PMC2426750          DOI: 10.1038/sj.ki.5002718

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  46 in total

Review 1.  An intact renin-angiotensin system is a prerequisite for normal renal development.

Authors:  G Guron; P Friberg
Journal:  J Hypertens       Date:  2000-02       Impact factor: 4.844

Review 2.  Regulation of the angiotensin AT1 receptor by hypercholesterolaemia.

Authors:  G Nickenig; S Wassmann; M Böhm
Journal:  Diabetes Obes Metab       Date:  2000-08       Impact factor: 6.577

Review 3.  The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease.

Authors:  S Klahr; J J Morrissey
Journal:  Kidney Int Suppl       Date:  2000-04       Impact factor: 10.545

4.  Decreased urinary citrate excretion in type 1a glycogen storage disease.

Authors:  D A Weinstein; M J Somers; J I Wolfsdorf
Journal:  J Pediatr       Date:  2001-03       Impact factor: 4.406

5.  High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells.

Authors:  H Ha; M R Yu; H B Lee
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

Review 6.  International union of pharmacology. XXIII. The angiotensin II receptors.

Authors:  M de Gasparo; K J Catt; T Inagami; J W Wright; T Unger
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

7.  Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.

Authors:  B L Riser; P Cortes
Journal:  Ren Fail       Date:  2001 May-Jul       Impact factor: 2.606

Review 8.  Angiotensin II and renal fibrosis.

Authors:  S A Mezzano; M Ruiz-Ortega; J Egido
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

Review 9.  Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis.

Authors:  S Gupta; M R Clarkson; J Duggan; H R Brady
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

Review 10.  The role of protein kinase C activation and the vascular complications of diabetes.

Authors:  Net Das Evcimen; George L King
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

View more
  19 in total

Review 1.  Glomerular diseases: genetic causes and future therapeutics.

Authors:  Chih-Kang Chiang; Reiko Inagi
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

2.  In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.

Authors:  Dwight D Koeberl
Journal:  J Inherit Metab Dis       Date:  2012-02-07       Impact factor: 4.982

Review 3.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

Review 4.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

5.  Glycogen Storage Disease Type I Presenting with Hypertension During Infancy.

Authors:  Eshita Bhowmik; Moumita Ghosh; Tapas Kumar Sabui; Rakesh Mondal
Journal:  Indian J Pediatr       Date:  2015-03-05       Impact factor: 1.967

6.  Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector.

Authors:  Xiaoyan Luo; Gentzon Hall; Songtao Li; Andrew Bird; Peter J Lavin; Michelle P Winn; Alex R Kemper; Talmage T Brown; Dwight D Koeberl
Journal:  Mol Ther       Date:  2011-07-05       Impact factor: 11.454

7.  Angiotensin II stimulates fibronectin protein synthesis via a Gβγ/arachidonic acid-dependent pathway.

Authors:  Larry D Alexander; Yaxian Ding; Suganthi Alagarsamy; Xiaolan Cui
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-11

8.  Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy.

Authors:  Julie Clar; Blandine Gri; Julien Calderaro; Marie-Christine Birling; Yann Hérault; G Peter A Smit; Gilles Mithieux; Fabienne Rajas
Journal:  Kidney Int       Date:  2014-04-09       Impact factor: 10.612

9.  Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7).

Authors:  Michiya Igase; Hiroshi Yokoyama; Carlos M Ferrario
Journal:  Ther Adv Cardiovasc Dis       Date:  2011-11-16

Review 10.  Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.

Authors:  Fabienne Rajas; Julie Clar; Amandine Gautier-Stein; Gilles Mithieux
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.